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Introduction
Pharmaceuticals, personal care products, food additives, and plastics, among others, are considered essential to modern lifestyle. Nevertheless, many of these chemical compounds have been found in unexpected regions. For example, the antiviral medication Tamiflu was found in surface waters in United Kingdom (Singer et al., 2007) ; 17 micropollutants (e.g., bisphenol A (BPA), diclofenac, naproxen, di-2-ethylhexylphthalate (DEHP), triclosan, etc.) were determined in surface and ground waters in Mexico City (Félix-Cañedo, 2013) ; and even illicit drugs have been found at selected locations of the Colorado Basin in the United States (Jones-Lepp et al., 2012) . The toxicity data of these molecules are not completely available or have not yet been fully investigated. Thus, assessing the impact of these molecules on human health has become a pressing need for global agencies and institutes aimed at protecting public health and environment care, such as the World Health Organization (WHO) and the European Commission (Falconer et al., 2006; Hutchinson et al., 2013; Mc Clellan & Halden, 2010) . Some contaminants with particular chemical structures and properties that interfere with endocrine systems have been of increasing interest. These endocrine-disrupting chemicals (EDCs) are poorly regulated, and information on their environmental impact is currently incomplete (Campbell et al., 2006; Kundakovic & Champagne, 2011; Petrovic et al., 2004) . However, preliminary results from in vivo models, and epidemiological and clinical studies, have shown that EDCs play a role in diseases such as breast cancer and prostate cancer; metabolic diseases such as obesity; and effects on the human reproductive, thyroid, cardiovascular, and neuroendocrinology systems. Therefore, it has become a global public health issue (Anway et al., 2005 : Diamanti-Kandarakis et al., 2009 Gore et al., 2011; Kundakovic & Champagne, 2011; Li et al., 1997; Mc Lachlan, 2001; Svechnikov et al., 2010) .
Besides wastewaters, other sources of EDCs related to human activity are present, for example, in high-volume horizontal hydraulic fracturing. This new mining technique is employed for shale gas extraction, using chemicals known to exert neurotoxic, carcinogenic, and endocrine-disrupting effects. The economic implications of natural gas extraction have resulted in insufficient investigation into the health implications (Rafferty & Limonik, 2013 ). Furthermore, the information related to nanoparticles and carbon nanotubes has raised in the last years (Iavicoli et al., 2013; Lam et al., 2006; Lanone et al., 2013; Lu et al., 2013; Nel et al., 2006) .
Sampling and identification of EDCs in environmental matrices is expensive and time consuming. In this regard, the US Environmental Protection Agency (EPA) has proposed various methods for EDC screening, considering factors such as persistence, bioaccumulation potential, and toxicity (PBT approach). Nevertheless, this strategy has been criticized as it overlooks chemical usage rates and real-world biodegradability (Venkatesan & Halden, 2014) .
Identification of novel substances such as EDCs should be based on their long-term effects in organisms and the environment beyond the conventional accumulation, distribution, metabolism, or excretion analysis. Epigenetics can lead to a gene expression change in response to ambient factors and can inherit potential adverse alterations underlying the genome, as reported by Guerrero-Bosagna et al., (2013) . Therefore, environmental matrices can be measured in terms of general epigenetic activity. Many of the mechanisms by which EDCs exert their genotypic and phenotypic effects remain unknown, but there is emerging evidence related to epigenetic deregulation. Consequently, efforts related to toxicology and safety assessment have focused on epigenetic mechanisms related to exposure to chemical compounds in vitro and in vivo (Greally, 2011) . In this review, we suggest environmental monitoring of EDCs by measuring their epigenetic effects through the analysis of DNA methylation.
Epigenetics and mechanisms of EDCs
In 1942, Conrad H. Waddington introduced the epigenetics term and described the multiple ways in which epigenetics can regulate gene expression, resulting in a particular phenotype. In fact, epigenetics research includes a variety of events, such as messenger RNA (mRNA) silencing through microRNAs (miRNAs), chromatin remodeling, histone modifications, and DNA methylation. Histone modification and DNA methylation are heritable events, but they do not involve DNA changes or mutations (Jaenisch & Bird, 2003) .
Hormones are known to be signaling molecules capable of modifying gene expression in non-mammalian and mammalian vertebrates. The changes in gene expressions could be determined by DNA methylation and chromatin modifications (Andres et al., 1984; Anway et al., 2005; Edinger et al., 2013) . Cellular imprinting by EDCs may be caused by two mechanisms: the EDC may imprint the gene either through a process leading to genetic change (e.g., DNA methylation) or by altering key steps in cell differentiation signaling pathways such that gene expression could form a biochemical memory (McLachlan, 2001) .
In order to understand the process by which EDCs interact and regulate gene expression, it is important to note that genes are not expressed alone but rather in the context of other genes and their products, cells, and tissues in a temporal/spatial dimension (Crews & McLachlan, 2006) . If an external stimulus like an emerging contaminant alters endogenous hormone secretion or sensitivity of tissues, then alternative development pathways could be present due to these endocrine interactions (Nijhout, 2003) .
EDCs affect the anatomical development and histological organization of male and female reproductive structures, resulting in fertility issues, as well as cancer of the female reproductive tract. Therefore, it is logical to assume that EDCs act by interacting with the respective sex hormone receptors (Bernal & Jirtle, 2010; Gore et al., 2011; Guerrero-Bosagna et al., 2013; Knower et al., 2014; Svechnikov et al., 2010; Uzumcu et al., 2012) .
The interaction of EDCs with sex hormone receptors can trigger signaling pathways that generate epigenetic changes in DNA methylation, which may be heritable, resulting in gene expression changes without DNA sequence mutations (Alworth, 2002; Anway et al., 2005; Kundakovic & Champagne, 2011; Li et al., 1997) . Epigenetic changes involved in cell differentiation in affected tissues are common, which were first demonstrated by Li et al. in 1997 . The authors discovered that upon exposure to a synthetic estrogen, diethylstilbestrol (DES), female mice showed an altered pattern of CpG methylation in the lactotransferrin gene promoter region in the uterus. Specifically, an abnormal demethylation of a CpG island occurs in response to neonatal DES exposure and adult ovarian hormones. These experiments led to the hypothesis that DES, and other environmental estrogens, can alter the estrogen-mediated differentiation of reproductive tract target cells, that is, an epigenetic mechanism. Furthermore, in gestating female rats, Anway et al. (2005) demonstrated that transient exposure to EDCs such as vinclozolin (antiandrogenic compound) or methoxychlor (estrogenic compound) of during the gonadal sex determination period induced a decrease in spermatozoid viability and cell number in the first-generation adult phenotype, thus male infertility increase. The decrease in spermatogenic production was inherited through four subsequent male generations. Moreover, abnormalities during pregnancy such as anemia, preeclampsia, and blood cell defects, were observed. Although, sexual differentiation effects and infertility have been correlated with DNA methylation changes, no evidence of the role of specific genes in these events was reported.
Nevertheless, the whole genome effect has been elucidated. Epigenomic changes caused by EDCs might lead to transgenerational inheritance due to their wide distribution and the stability of target cells (Greally, 2011) .
Other epigenetic mechanisms involve molecular regulators such as histone variant, histone post-translational modifications, nucleosome positioning chromosome looping, DNA structural variations, and RNA-mediated regulation (Beiter et al., 2009; Bernstein et al., 2007; Gibney & Nolan, 2010; Hartley & Madhani, 2009; Hiragrami-Hamada et al., 2009; Jia et al., 2007; Klose & Bird, 2006) . These mechanisms are closely related to chromatin conformation and, therefore, polymerase accessibility for gene expression. Studies have suggested an ordered pathway for chromatin architecture conformation, because nucleosome positioning requires histone deposition and sequences such as nucleosome-free regions (NFRs) (Hartley & Madhani, 2009 ).
Regarding genetic regulation mediated by histone modifications, Hiragami-Hamada et al.
(2009) demonstrated that gene silencing was associated with histone H3 trimethylation at lysine 9 (H3K9me3) in an animal model. They also showed that histone H3 acetylation at lysine 4 and di-or tri-lysine methylation (H3K4me2/3) were very common modifications related to changes in gene expression. These and other histone modifications were associated with transcription regulation; however, no known histone code was related to the regulation processes mediated by hormones, and neither were these modifications associated with EDCs.
The study of miRNAs as epigenetic regulators of gene expression has expanded significantly in recent decades, although it remains a developing area, because a single miRNA can have several target mRNAs and can be regulated by different miRNAs (Klein et al., 2005; Kosik, 2006; Zhang & Ho, 2014) . Several predictive software to determine putative targets of different miRNAs are available, but the generation rate of false positives is still high; thus, experimental evidence is necessary (Wang & Wang, 2006) . Experimental findings have shown a relationship between miRNA activity and the respective targets.
However, cells show different types of epigenetic regulation depending on the cell environment and stimulus received. In addition, it has been observed that the regulation process is related to tissue and is time specific, so different phenotypes are produced (Fraga et al., 2005; Greally, 2011; Thompson et al., 2010) .
Further work is needed in order to establish regulation marks in different genomic contexts, since its understanding remains elusive. Fortunately, considerable insights have been gained and, thus far, techniques improved especially in whole-genome methylation that describes the association of epigenetic changes with exposure to EDCs in cells.
In this review, we focused on DNA methylation, since manipulation of methylation patterns is often lethal. Moreover, findings regarding maladaptive traits confirm the relevance of DNA methylation in human biological development as well as other living organisms (Crews, 2009 ).
Analysis of epigenetic mechanisms through DNA methylation
The epigenetic and epigenome regulation has been elucidated through the genes implicated in endocrine signaling such as DNA methylation (Fig. 1) (Zhang & Ho, 2014) . Although several epigenetic regulators are present, most studies usually focus on cytosine methylation assays, which can be quantitative strand-specific, and allow nucleotide resolution (Suzuki et al., 2010) ; also, could involve methylation on a locus-specific or genome-wide scale (Shen & Waterland, 2007) . Almost all techniques require DNA pretreatment for enrichment of methylated DNA. These approaches are based on restriction enzymes (REs), bisulfite conversion, and affinity enrichment, and some combinations thereof (Laird, 2010) .
RE assays use methylation-dependent REs and are currently the most commonly used methods for epigenetic analysis. The coverage and resolution depend on the recognition sequences throughout the genome. However, RE assays can only analyze CpGs sites within the RE action range; thus, incomplete digestion may cause false positives. Differential methylation hybridization (DMH) is an example of an epigenomic analytical technique based on RE assays. In DMH, genomic DNA is fragmented with a methylation-independent RE. Then, these fragments are ligated with adaptors. Next, the DNA is digested with the methylation-sensitive enzyme BstUI; it is then, it is PCR-amplified, labeled, and co-hybridized to CpG island microarrays (Yan et al., 2009) .
Bisulfite conversion is an accurate and reproducible technique that takes advantage of the deamination capacity of unmethylated cytosines by sodium bisulfite, and its later conversion to uracil or thymine at higher rates than methylated cytosines. This method represents the gold standard for detecting changes in DNA methylation due to a nucleotidelevel resolution and detection of methyl-specific single-stranded DNA (ssDNA) as a conversion or simple overtreatment. Some sequencing methods based on bisulfite conversion include bisulfite sequencing (BS), pyrosequencing, and combined bisulfite restriction analysis (COBRA).
In the BS method, bisulfite-treated DNA is PCR-amplified with methylation-independent primers (methylation-specific PCR or MSP) and size-fractionated via gel electrophoresis (Darst et al., 2010; Herman et al., 1996) . The products purified by PCR were cloned into Escherichia coli, and five to ten individual clones were sequenced. The Infinium Methylation Assay is a commercial example of this approach (Dedeurwaerder et al., 2011) .
COBRA is a variation of BS, and it combines bisulfite conversion, amplification PCR, and RE digestion with BstUI (Xiong & Laird, 1997) . In the pyrosequencing method, bisulfitemodified DNA is amplified with the enzyme DNA polymerase and then sequenced with specific primers. During the formation of the complementary DNA strand, pyrophosphate (PPi) is released, forming adenosine triphosphate (ATP), which supplies the energy to produce a luciferase-luciferin-adenosine monophosphate (AMP) complex. In the presence of oxygen, this complex showed a proportional light signal to ATP concentration and, consequently, to PPi. (Colella et al., 2003; Tost et al., 2003) . Some companies have developed assays for pyrosequencing such as PyroMark CpG Assays (England & Pettersson, 2005) .
Assays involving affinity for enrichment methylated regions are based on the use of specific antibodies against 5-methylcytosine (5meC) to recover ssDNA, or the use of methyl-binding proteins to enrich methylated DNA. As this technique does not require RE digestion or bisulfite conversion, it does not provide information at the nucleotide level.
Moreover, it requires large quantities of input genomic DNA and intensive labor, which can limit the processing of large number of samples. However, low quantities of input DNA can be recovered by amplification methods. The efficiency of coverage and resolution depends on the genomic distribution of potential affinity targets (methyl-cytosine density) and subsequent approaches (array composition or sequencing platform). Methylated DNA immunoprecipitation (MeDIP) and Methylated CpG Island Recovery assay (MIRA) are based on enrichment assays. In MeDIP, the DNA is sheared through sonication, denatured, and immunoprecipitated with an antibody against 5meC. Then, the methylated DNA is analyzed by microarrays or sequencing (Weber et al., 2005) . MIRA assays involve the digestion of DNA with either MseI enzyme or sonication. Then, the sheared DNA is bound to an adaptor and incubated with MBD2b/MBD3L1 proteins. Finally, the enriched DNA is amplified and analyzed by sequencing or microarrays (Rauch & Pfeifer, 2005) .
Sequence-based analysis is more flexible and powerful as it allows the analysis of allelespecific DNA methylation and requires less input DNA. Epigenetic strategies for locus- Genome-wide epigenetic studies include microarrays and sequencing technologies, which are actively used for high-resolution mapping of the chromatin structure and DNA methylation (Boyle et al., 2008) . To study a candidate gene, targeting their promoter is usually the simplest approach. Candidate genes are mostly selected for their function, phenotype effect, or differential expression compared to a control group (Levenson & Malmikov, 2012) . The advantages of this approach are less time and cost; moreover, it is a quantitative assay providing comprehensive and unbiased insights (Greally, 2011) .
Of all epigenetic modifications, DNA methylation is most widely studied, due to its heritable nature, stability, and ease of measurement. Consequently, the majority of studies on the epigenetic effects of EDCs focus on these modifications. Table 1 describes some of the techniques already mentioned, as well as their respective advantages and limitations.
Many of these analytical techniques involve high-cost instrumentation, highly trained operators, a time-consuming detection process, and complex pretreatment steps.
Environmental epigenomics is an emerging field, and its main goal is developing rapid detection technologies and accurate epigenome-wide assessment methods (Jirtle & Skinner, 2007) . Further work is needed to evaluate the epigenetic effects of exposure to EDCs. In particular, genome-wide assays will play an important role in findings of methylation patterns, profiles, or levels, including imprinted genes and their relationship with emerging pollutants in the environment. Platform development and cost reduction of genomic technologies can promote further exploration of induced epigenetic alterations due to EDCs. Experimental data should be analyzed and integrated into biological systems through computational epigenomics to understand epigenetic regulatory mechanisms. In addition, the insights obtained can lead to novel approaches for EDC detection and environmental monitoring, including valid analytical methodologies and portable devices such as biosensors.
Conclusions
Chemical compounds found in pharmaceutical drugs, personal care products, food additives, and food containers interfere with endocrine systems since are involved in diseases such as prostate and breast cancer, metabolic diseases, and effects on the human reproductive, thyroid, cardiovascular, and neuroendocrinology systems. These endocrinedisrupting chemicals (EDCs) are not wide regulated, and the documentation of their environmental effects is poor.
Identification, detection and treatment of novel EDCs should be founded on their long-term effects in organisms as well as the environmental impact beyond the conventional analysis of accumulation, distribution, metabolism, or excretion. In this regard, environmental matrices can be measured in terms of general epigenetic activity due to a gene expression changes occurs in response to ambient factors and can inherit potential adverse alterations underlying the genome. The changes in gene expressions could be determined by DNA methylation and chromatin modifications.
The epigenetic and epigenome regulation has been studied through the genes involved in endocrine signaling and their relationship with emerging pollutants in the environment.
DNA methylation is the most studied, due to its heritable nature, stability, and ease of measurement. Analytical techniques are based on restriction enzymes (REs), bisulfite conversion, and affinity enrichment.
Data science as well as cost reduction of genomic technologies will stimulate the understanding of the EDCs role on epigenetic regulatory mechanisms. In addition, the insights obtained could lead to novel approaches for EDC detection and environmental monitoring, including valid analytical methodologies and portable devices such as biosensors. 
Bisulfite conversion
-High-throughput for sitespecific detection -Accurate and high resolution for methylation variable positions. -Methylation in most types of repetitive sequences.
-High instrumentation costs.
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